Humana, Inc.

  • 2 Magic Formula Pick's With Headline Risk

    By Adem Tahiri - August 6, 2013 | Tickers: HUM, WLP

    Investors like a good deal. The problem is, most of us wouldn't know a bargain if it hit us in the face.

    At least that's what hedge fund manager and value investing icon Joel Greenblatt says. In a series of books and lectures, Greenblatt has touted his "magic formula" for stock picking. Greenblatt argues that by following the simple formula we can take the guesswork out of picking more »

  • Top U.S. Health Insurance Companies Capitalizing on Reforms

    By Shweta Dubey - August 2, 2013 | Tickers: HUM, UNH, WLP

    After the recent introduction of healthcare reforms, the health insurance industry in the U.S. is expected to benefit from rising demand. Healthcare reforms such as the formation of health insurance exchanges and the government providing health insurance to citizens who cannot afford it will be the primary contributors to this growth. These reforms are expected to add 25 million U.S. citizens to the overall health insurance market. Three more »

  • 3 Key Takeaways From UNH's Q2

    By Brandy Betz - July 25, 2013 | Tickers: AET, HUM, UNH

    Dow component UnitedHealth Group (NYSE: UNH) closed last week up over 6% thanks to a mostly positive second quarter report. Revenues grew 12%, year-over-year, to $30 billion. Health services business Optum saw a 21% revenue growth, and a nearly 70% growth in operating earnings.

    But there’s more buried slightly deeper in the quarter’s results. UnitedHealth’s involvement in Obamacare will continue to evolve over the next year. And more »

  • UnitedHealthGroup: A Foolish Buy!

    By Kiran Gulati - July 2, 2013 | Tickers: AET, HUM, UNH

    UnitedHealth (NYSE: UNH) is one of the largest diversified healthcare companies in the world and the largest in the United States if not the entire North American continent. The company has a diversified set of product lines with the ultimate objective of providing affordable healthcare to millions.

    Last year was a successful one for UnitedHealth. In spite of finding itself surrounded by a tumultuous economic environment, the company recorded revenue more »

  • Billionaire Ray Dalio’s Inexpensive Stock Picks

    By Meena Krishnamsetty - June 30, 2013 | Tickers: HUM, INTC, LMT, NOC, UNH

    In May, Bridgewater Associates -- one of the largest hedge funds in the world, managed by billionaire Ray Dalio -- filed its 13F for the first quarter of 2013. Even though the information in 13Fs is a bit old, we believe that there are still ways for investors to make use of it. For one, we have found that the most popular small cap stocks among hedge funds earn an average excess more »

  • A Rigged Market? It's OK With Me

    By Bob Chandler - June 18, 2013 | Tickers: DECK, HUM, WLP | Editor's Choice

    There seems to be plenty of evidence suggesting that some players in the market have a significant advantage when compared to the average investor. While it’s legal, it also implies the market is hardly a level playing field. But this is OK. Individual investors can still profit from this rigged game, and they can even capitalize on big players' advantages.

    Are markets rigged?

    Having greater access to information, greater more »

  • Billionaire Leon Cooperman's Shakeups

    By Marshall Hargrave - May 25, 2013 | Tickers: EMN, HUM, PCLN, S

    Billionaire Leon Cooperman grew up as the son of a plumber living in the South Bronx, then worked his way into Hunter College as a Xerox quality control engineer in the mid-60's. Later, Cooperman went to Columbia Business School for an MBA.

    After a 25-year career with Goldman Sachs, Cooperman founded Omega Advisors in 1991. Outlined below is some of the interesting takeaways from Omega's recent buys and more »

  • This Healthcare Company Is Cheap

    By Anh HOANG - May 13, 2013 | Tickers: CI, HUM, UNH

    Over the past year, Humana (NYSE: HUM) shares have performed sluggishly. Since May 2012, Humana has been quite volatile, fluctuating in the range of $59.90 to $82.50 per share. The share price has declined 5.9% in the past twelve months. According to Barron’s, JPMorgan has recently upgraded the company from Neutral to Overweight, with a $91 price target, a 20.5% premium to its current trading more »

  • Healthcare Changes Provide New Opportunities

    By Austin Higgins - April 22, 2013 | Tickers: AET, CI, HUM

    The Affordable Care Act will require certain changes in the market with regards to insurance coverage, employment benefits, and the cost of hiring employees. Companies that can offer viable solutions to people and other organizations will provide excellent opportunities to investors.

    The product

    An interesting insurance product that offers short-term flexibility and lower premiums is the short-term medical plan. These plans offer similar coverage as the major medical plans. The more »

  • Has This Health Care Provider Risen Too Far?

    By Matthew Frankel - April 18, 2013 | Tickers: AET, CI, HUM

    Aetna (NYSE: AET) is one of the leading providers of health insurance products and services in the US.  Out of the 803 health insurance companies in the U.S., Aetna is the third largest by enrollment.  After some good quarterly reports, Aetna is now up almost 65% since last July.  There is no doubt that Aetna is a solid company that is performing very well; my question is whether or more »

  • Has This Health Care Provider Risen Too Far?

    By Matthew Frankel - April 16, 2013 | Tickers: AET, CI, HUM

    Aetna (NYSE: AET) is one of the leading providers of health insurance products and services.  Out of the 803 health insurance companies in the U.S., Aetna is the third largest by enrollment.  After some good quarterly reports, Aetna is now up almost 65% since last July.  There is no doubt that Aetna is a solid company that is performing very well; my question is whether or not all of more »

  • More Upside in Store for This Healthcare Insurance Provider

    By Nick Chiu - April 12, 2013 | Tickers: CI, HUM, UNH, WLP

    For investors seeking high revenue growth with an inexpensive free cash flow in the health insurance industry, Cigna is one of the top investment targets. Cigna (NYSE: CI), with a market cap of $18.46 billion, is a global health services company, providing medical, dental, disability, life, and accident insurance through its subsidiaries. Cigna continues to improve its bottom line. Unlike other health plan providers, Cigna's impact by Affordable more »

  • Why this health care insurance provider is due for more upside

    By Nick Chiu - April 7, 2013 | Tickers: CI, HUM, UNH, WLP

    Cigna (NYSE: CI), with a market cap of $18.46 billion, is a global health services company, providing medical, dental, disability, life and accident insurance through its subsidiaries. Cigna had been trading in the range of $39.01-$66.67 in the past 52 weeks.

    Improving Patience Access

    Cigna continues to improve patient access to health care by enhancing care coordination and aiming to achieve improved health, affordability and patient more »

  • Health Insurers Get a Shot in Arm, But the Boost Could Be Temporary

    By Diane Alter - April 3, 2013 | Tickers: HUM, UNH, WLP

    Medicare advantage health insurers got a shot in the arm after planned government cuts in payments were squashed. But the boost to shares could be temporary and is not a cure-all for what ails health insurers.

    The Centers for Medicare and Medicaid Services (CMS) had originally proposed a 2.3% reduction in what the government pays to Medicare Advantage plans. In a stark about face, the CMS on April 1 more »

  • Billionaire Andreas Halvorsen’s High Upside Potential Stocks

    By Meena Krishnamsetty - April 2, 2013 | Tickers: COF, C, HUM, SNDK, SLB

    We track 13F filings from hedge funds and other notable investors for a variety of purposes. First, it helps us in our work researching investment strategies. Second, we can treat ownership by a particular hedge fund similarly to a stock screen (as a source of free investment ideas) and combine ownership with other criteria, including a low PEG ratio (a low PEG ratio is an indicator of upside potential in more »

  • Obamacare is No Bust for Insurance Stocks

    By Jordan Wathen - April 2, 2013 | Tickers: CI, HUM, UNH

    Thought Obamacare was sure to crush the insurance industry?

    Think again.

    After the markets closed Monday, the US government reversed its decision to lower payouts to Medicare Advantage plans, offering a 3.3% increase in payment rates instead of the 2.3% decrease it had previously announced.

    Why Medicare payment rates matter

    Falling reimbursement rates can crush health insurance companies like Humana (NYSE: HUM) or United Healthcare (NYSE: UNH). Health more »

  • Are These 3 Healthcare Insurers Worth The Risk?

    By Bill Edson - March 15, 2013 | Tickers: AET, CI, HUM, UNH

    There are a lot of questions about how the new healthcare laws will impact insurance companies. Obviously investors should not swear off healthcare stocks, but they should require a discount to embrace this risk. Unfortunately, the prices of many of these stocks are not compelling. I will examine Humana (NYSE: HUM), Aetna (NYSE: AET) and UnitedHealthCare Group (NYSE: UNH) in the context of these new healthcare laws to see if more »

  • Red Light, Green Light with Humana

    By Irving Harrison - March 3, 2013 | Tickers: HUM, UNH, WLP

    Investing should be simple. Red Light, Green Light is a simple children’s game. In this game, one person plays the "stop light" and the rest try to touch him/her. The stoplight faces away from a line of kids and says “green light.” At this point the kids are allowed to move towards the stoplight. At any point, the stoplight may say "red light!" and turn around. If any more »

  • Health Premiums and Insurance Stocks

    By Nate Wooley - February 25, 2013 | Tickers: AET, CI, HUM, UNH

    A new study released by the U.S. Department of Health and Human Services indicates that the rise of health insurance premiums year-to-year is slowing significantly. In the report, the number of health insurers raising rates by more than 10% dropped from 74% in 2009 to a preliminary 14% in 2013. Whatever the reason, no one can argue that's not a huge drop in the rate of increase.

    And more »

  • The Real Duck Dynasty

    By Diane Alter - February 15, 2013 | Tickers: AFL, HUM, WLP

    Aflac (NYSE: AFL) shares slumped after reporting fourth quarter results that signaled slowing growth. But don't get your feathers ruffled--Aflac should keep investors happy as a duck in water.

    The supplemental health and life insurer, best recognized by its signature mascot (a pristine white duck), reported that Q4 revenue rose 6.6% to 6.4 billion and net earnings were $581 million, or $1.24 a share. That was more »

  • Page 1 of 2